LeonaBio, Inc. (LONA) income statement
LONANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$2.02−0.44 (-17.89%)
Close on Nov 20, 2026Market cap $19.03MP/E –Yield –
LeonaBio, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- -290.8%
Financial strength
- Current ratio
- 7.01
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 413.5%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.57
- Dividend yield
- –
See a number that looks wrong?